|
|
|
|
| LEADER |
01688nam a22003135i 4500 |
| 001 |
978-1-59259-617-1 |
| 005 |
20190618031415.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s1989 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781592596171
|
| 024 |
7 |
|
|a 10.1385/0896031225
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Drugs as Tools in Neurotransmitter Research
|c edited by Alan A. Boulton, Glen B. Baker, Augusto V. Juorio.
|
| 250 |
|
|
|a 1st ed. 1989.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 1989.
|
| 300 |
|
|
|a XVIII, 512 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Neuromethods,
|v 12
|
| 505 |
0 |
|
|a Neurotoxins That Affect Central and Peripheral Catecholamine Neurons -- Neurotoxins that affect central indoleamine neurons -- Toxins Affecting Cholinergic Neurons -- GABA Antagonists -- Specificity of Drugs as Tools in Psychopharmacology -- Determination of Monoamine Turnover by Blockade of Their Synthesis or Metabolism -- Dopamine Receptors and Neuroleptic Drugs -- Use of 5-HT Receptor Agonists and Antagonists for the Characterization of Their Respective Receptor Sites -- Biochemical Models of Parkinson’s Disease -- Drug-Induced Behavioral Models of Central Disorders -- Determination of Acetylcholine Dynamics.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
1 |
4 |
|a Neurosciences.
|
| 700 |
1 |
|
|a Boulton, Alan A.
|e editor.
|
| 700 |
1 |
|
|a Baker, Glen B.
|e editor.
|
| 700 |
1 |
|
|a Juorio, Augusto V.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1385/0896031225
|